GDMC: Funding, Investors & Team (Sep 2026)
GDMC is a pharmaceutical organization that specializes in the production and development of genetic medications.
GDMC has raised $21.0M across 1 funding round on record, the most recent a Series A of $21.0M announced in Jan 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GDMC Company Profile and Key Stats
Latest funding round on record: Jan 2024.
GDMC Funding Rounds
GDMC Founders and Leadership Team
No contact details are on record for this team yet.
GDMC Funding Compared to Other Biotechnology Startups
GDMC's latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GDMC in Biotechnology and Bukit Merah
Companies Similar to GDMC
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
Automera dedicates itself to the creation of innovative therapeutic approaches for drug development.
GDMC Funding FAQs
What does GDMC do?
GDMC is a pharmaceutical organization that specializes in the production and development of genetic medications.
How much funding has GDMC raised?
GDMC has raised $21.0M across 1 round on record. The most recent is a Series A of $21.0M announced in Jan 2024.
When did GDMC last raise funding?
GDMC's most recent funding round on record is a Series A of $21.0M, announced in Jan 2024.
Who founded GDMC?
FundedIQ lists Artur Gall (Founder) at GDMC.
Where is GDMC headquartered?
GDMC is based in Bukit Merah, Central Region, Singapore.
How many employees does GDMC have?
GDMC is in the 51-100 employee band.
How does GDMC's funding compare to other Biotechnology startups?
GDMC's latest round of $21.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's GDMC Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GDMC is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.